Anthem Biosciences IPO Allotment Announced: Steps to Check Status Online

On July 17, 2025, Anthem Biosciences Ltd announced the allotment status of its initial public offering (IPO), which has garnered significant interest from investors. The IPO, which opened for bidding from July 14 to July 16, received an overwhelming response, leading to a subscription rate of approximately 63.86 times. The company is set to list its equity shares on both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) on July 21, 2025.

The IPO was launched with a price band fixed at ₹570 per share, with a total capital raise of ₹3,395 crore from an offer-for-sale (OFS) of 5.96 crore equity shares. The strong demand was particularly notable in the Qualified Institutional Buyers (QIB) category, which saw a subscription rate of 182.65 times, indicating robust institutional interest in the company’s shares. The retail portion was subscribed 5.64 times, while the Non-Institutional Investors (NII) segment received a subscription of 42.36 times, reflecting broad-based appetite across investor categories.

According to Kfin Technologies, the official registrar for the IPO, the allotment status can be checked online through multiple platforms, including the BSE and NSE websites, as well as the Kfin Technologies portal. Investors can follow these steps to check their allotment status:

**BSE**: 1. Navigate to the BSE website's allotment status page. 2. Select ‘Equity’ in the Issue Type. 3. Choose ‘Anthem Biosciences Limited’ from the dropdown menu. 4. Input either the Application Number or PAN. 5. Complete the CAPTCHA verification and click ‘Search’.

**NSE**: 1. Visit the NSE allotment status page. 2. Select ‘Equity and SME IPO bids’. 3. Choose ‘Anthem Biosciences Limited’ in the Issue Name dropdown. 4. Enter the PAN and Application Number. 5. Click ‘Submit’ to view the status.

**Kfin Technologies**: 1. Access the Kfin Technologies portal. 2. Select ‘Anthem Biosciences Limited’ from the IPO dropdown. 3. Choose either Application Number, Demat Account, or PAN. 4. Input the relevant details and complete the CAPTCHA. 5. Click ‘Submit’ to check your status.

The Grey Market Premium (GMP) for Anthem Biosciences shares is currently at ₹144, indicating a strong trading sentiment in the grey market, which suggests that shares may list at approximately ₹714 each, a 25.26% premium over the IPO price.

In light of the IPO's success, market analysts have noted that the performance of Anthem Biosciences reflects a continuing trend in the Indian IPO market, which, while cooling compared to previous highs, still shows potential for well-received offerings. The significant over-subscription rates indicate a healthy investment appetite in the biotechnology sector, particularly as the industry continues to evolve and expand its market share.

As the IPO listing date approaches, stakeholders are closely monitoring the developments, as the reception of Anthem Biosciences in the public markets could set the tone for future biotechnology IPOs in India. Investors and analysts alike will be keen to see how the shares perform post-listing, which could provide insights into broader market trends and sector health.